In beta cells, biotin-stimulated cGMP synthesis likewise boosts glucokinase expression, helping to correct a down-regulation of glucokinase activity that plays a key role in the beta cell dysfunction characteristic of type 2 diabetes [222,223,224,225,226]. This evidence concerns the gene GCK and type 2 diabetes mellitus.